Ormet 400 mg (Tablet)
Medicine Details
| Category | Details |
|---|---|
| Generic | Metronidazole |
| Company | Belsen pharmaceuticals ltd |
| Also available as |
Title
Ormet 400 mg Tablet
Categories
- Antibiotic
- Antiprotozoal
- Amoebicide
- Anti-diarrhoeal
Description
Ormet is indicated in the treatment of various diseases including post-operative infections, septicaemia, trichomoniasis, bacterial vaginosis, amoebiasis, giardiasis, gingivitis, leg ulcers, anaerobic infections, surgical prophylaxis, etc. It is a member of the imidazole class of antibacterial drugs and is classified therapeutically as an antiprotozoal agent. It has multiple dosage forms and recommended doses for different conditions. It also has potential drug interactions, contraindications, and side effects. It is categorized under US FDA Pregnancy Category B and caution is advised during pregnancy and lactation. Ormet should be administered with caution to patients with hepatic encephalopathy and renal impairment. Storage conditions and precautions for use in special populations are also mentioned. Additionally, there are common questions and tips related to its usage.
Dimensions
- Tablet
- Suspension
- Vaginal Gel
- Suppository
- IV Infusion
Color options
Functions
- Treatment of diseases
- Prevention of infections
- Antibacterial action
- Antiprotozoal action
Materials
- Metronidazole
- Imidazole class of antibacterial drug
Technical specifications
- 5-nitro group of Metronidazole is reduced by anaerobes metabolically
- Reduced form of this drug interacts with DNA
- Intravenous infusion requires no dilution
Design elements
Usability features
- Prevents the growth of bacteria and parasites
- Controls various infections in different body parts
Indications
- Prevention of post-operative infections due to anaerobic bacteria
- Treatment of septicaemia, trichomoniasis, bacterial vaginosis, amoebiasis, giardiasis, gingivitis, leg ulcers, anaerobic infections, surgical prophylaxis
Pharmacology
- Member of the imidazole class of antibacterial drug
- Classified therapeutically as an antiprotozoal agent
- 5-nitro group interaction with DNA for bactericidal action
Dosage and administration
- Various recommended doses for different diseases and age groups
- Different doses for adults and children
Interaction
- Disulfiram
- Alcohol
- Oral anticoagulant therapy
- Lithium
- Cyclosporin
- Phenytoin or phenobarbital
- 5-Fluorouracil
- Busulfan
Contraindications
- Hypersensitivity to Metronidazole or other Nitroimidazole derivatives
Side effects
- Metallic taste
- Nausea
- Vomiting
- Diarrhoea
- Drowsiness
- Rashes
Pregnancy and lactation
- Category B for pregnancy
- Caution advised during lactation
Precautions and warnings
- Hematological tests recommended if administered longer than usual duration
- Caution in patients with hepatic encephalopathy
- May darken urine
Use in special populations
- Hepatic impairment
- Renal impairment
Overdose effects
- Symptoms limited to vomiting, ataxia, slight disorientation
- No specific antidote
- Symptomatic and supportive treatment for suspected massive overdosages
Therapeutic class
- Amoebicides
- Anti-diarrhoeal
- Antiprotozoal
Storage conditions
- Store below 30°C
- Keep protected from light
- Keep out of reach of children
- Do not use after expiry date
Commonly asked questions
- Uses of Ormet 400 mg Tablet
- Side effects of Ormet 400 mg Tablet
- Contraindications to Ormet 400 mg Tablet
- Safety during pregnancy
- Effectiveness of higher than recommended dose
- Quick Tips for usage